Concepedia

Rajendra Singh

RS

17

Publications

593

Citations

13

H-Index

2008

Active since

Affiliations

University of Florida(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Johns Hopkins University

Research Triangle Park Foundation

Rajendra Singh is an author at University of Florida specializing in pharmacology, medicine, and drug analysis.

ORCID

Top concepts

Publications per year

2008–2021

17

Publications

17

Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

Kelly E. Dooley, Richard Kaplan, Noluthando Mwelase et al. · Clinical Infectious Diseases · 2019 · 108 citations · Full text

PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis

Zahoor Ahmad, Charles A. Peloquin, Rajendra Singh et al. · Antimicrobial Agents and Chemotherapy · 2010 · 84 citations · Full text

, , +17

A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098

Nicholas F. Brown, Matthew Williams, Hendrik‐Tobias Arkenau et al. · Neuro-Oncology · 2018 · 80 citations · Full text

Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma

Matthew J. Matasar, Myron S. Czuczman, Maria Alma Rodriguez et al. · Blood · 2013 · 64 citations · Full text

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study

Rolando M. Viani, Theodore Ruel, Carmelita Alvero et al. · Journal of the Pediatric Infectious Diseases Society · 2018 · 41 citations · Full text

Rows per page

1–5 of 17